Meta analysis of propranolol effects on gastrointestinal hemorrhage in cirrhotic patients

World Journal of Gastroenterology

Volumn 9, Issue 8, 2003, Pages 1836-1839

  Cheng, Jin Wei ^a   Zhu, Liang ^a   Gu, Ming Jun ^a   Song, Zhe Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROPRANOLOL;

ARTICLE; BIBLIOGRAPHIC DATABASE; CAUSE OF DEATH; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; MORTALITY; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; RISK; SECONDARY PREVENTION; STATISTICAL ANALYSIS;

EID: 0042928490     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i8.1836     Document Type: Article

References (34)

1. Luca A, Garcia-Pagan JC, Feu F, Lopez-Talavera JC, Fernandez M, Bru C, Bosch J, Rodes J. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis. Hepatology 1995; 21: 83-88
2. Albillos A, Perez-Paramo M, Cacho G, Iborra J, Calleja JL, Millan I, Munoz J, Rossi I, Escartin P. Accuracy of portal and forearm blood flow measurements in the assessment of the portal pressure response to propranolol. J Hepatol 1997; 27: 496-504
3. Escorsell A, Bordas JM, Feu F, Garcia-Pagan JC, Gines A, Bosch J, Rodes J. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: Effects of pharmacological therapy. Gastroenterology 1997; 113: 1640-1646
4. Egger M, Smith GD, Phillips AN. Meta-analysis: Principles and procedures. BMJ 1997; 315: 1533-1537
5. Egger M, Smith GD. Meta-analysis. Potentials and promise. BMJ 1997; 315: 1371-1374
6. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998; 351: 47-52
7. Burroughs AK, Jenkins WJ, Sherlock S, Dunk A, Walt RP, Osuafor TO, Mackie S, Dick R. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539-1542
8. Lebrec D, Poynard T, Bernuau J, Bercoff E, Nouel O, Capron JP, Poupon R, Bouvry M, Rueff B, Benhamou JP. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A final report. Hepatology 1984; 4: 355-358
9. Villeneuve JP, Pomier-Layrargues G, Infante-Rivard C, Willems B, Huet PM, Marleau D, Viallet A. Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trial. Hepatology 1986; 6: 1239-1243
10. Queuniet AM, Czernichow P, Lerebours E, Ducrotte P, Tranvouez JL, Colin R. Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients. Gastroenterol Clin Biol 1987; 11: 41-47
11. Pascal JP, Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987; 317: 856-861
12. The Italian Multicenter Project for Propranolol in Prevention of Bleeding. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: A multicenter, randomized clinical trial. Hepatology 1988; 8: 1-5
13. Marbet UA, Straumann A, Gyr KE, Beglinger C, Schaub N, Bogtlin J, Loosli J, Kiowski W, Ritz R, Stalder GA. Reduction in early recurrence of variceal bleeding by propranolol. Scand J Gastroenterol 1988; 23: 369-374
14. Colombo M, De Franchis R, Tommasini M, Sangiovanni A, Dioguardi N. Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial. Hepatology 1989; 9: 433-438
15. Sheen IS, Chen TY, Liaw YF. Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis. Liver 1989; 9: 1-5
16. Garden OJ, Mills PR, Birnie GG, Murray GD, Carter DC. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. Gastroenterology 1990; 98: 185-190
17. Andreani T, Poupon RE, Balkau BJ, Trinchet JC, Grange JD, Peigney N, Beaugrand M, Poupon R. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology 1990; 12: 1413-1419
18. Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodes J, Wright SC, Matloff DS, Garcia-Tsao G, Fisher RL, Navasa M, Drewniak SJ, Atterbury CE, Bordas JM, Lerner E, Bramante C. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology 1991; 13: 902-912
19. The PROVA Study Group. Prophylaxis of first hemorrhage from esophageal varices byn sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicenter trial. Hepatology 1991; 14: 1016-1024
20. Perez-Ayuso RM, Pique JM, Bosch J, Panes J, Gonzalez A, Perez R, Rigau J, Quintero E, Valderrama R, Viver J, Esteban R, Rodrigo L, Bordas JM, Rodes J. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991; 337: 1431-1434
21. Cales P, Oberti F, Payen JL, Naveau S, Guyader D, Blanc P, Abergel A, Bichard P, Raymond JM, Canva-Delcambre V, Vetter D, Valla D, Beauchant M, Hadengue A, Champigneulle B, Pascal JP, Poynard T, Lebrec D. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: A randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol 1999; 11: 741-745
22. Pascal JP. Prophylactic treatment of variceal bleeding in cirrhotic patients with propranolol: A multicentric randomized study. Hepatology 1984; 4: 1092
23. Cerbelaud P, Lavignolle A, Perrin D, Jutel P, Beaujard E, Colomb P, Le Bodic L. Gastroenterol Clin Biologique 1986; 10: 18
24. Mills PR, Garden OJ, Birnie GG, Carter DC. Propranolol in the prevention of further variceal hemorrhage in cirrhosis. Gastroenterology 1987; 92: 1755
25. Strauss E, De Sa MFG, Albano A, Lacet CMC, Leite MO, Maffei RA. A randomized controlled trial for the prevention of the first upper gastrointestinal bleeding due to portal hypertension in cirrhosis: Scleropathy or propranolol versus control groups. Hepatology 1988; 8: 1395
26. Colman J, Jones P, Finch C, Dudley F. Propranolol in the prevention of variceal haemorrhage in alcoholic cirrhotic patients. Hepatology 1990; 12: 851
27. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
28. De La Pena J, Rivero M, Sanchez E, Fabrega E, Crespo J, Pons-Romero F. Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: Prospective randomized trial. Gastrointest Endosc 1999; 49: 417-423
29. Umehara M, Onda M, Tajiri T, Toba M, Yoshida H, Yamashita K. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: A prospective randomized study. Gastrointest Endosc 1999; 50: 7-12
30. Masci E, Stigliano R, Mariani A, Bertoni G, Baroncini D, Cennamo V, Micheletti G, Casetti T, Tansini P, Buscarini E, Ranzato R, Norberto L. Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices. Hepatogastroenterology 1999; 46: 1769-1773
31. Hou MC, Lin HC, Kuo BI, Lee FY, Chang FY, Lee SD. The rebleeding course and long-term outcome of esophageal variceal hemorrhage after ligation: Comparison with sclerotherapy. Scand J Gastroenterol 1999; 34: 1071-1076
32. Hata Y, Hamada E, Takahashi M, Ota S, Ogura K, Shiina S, Okamoto M, Okudaira T, Teratani T, Maeda S, Koike Y, Sato S, Obi S, Tanaka T, Kawabe T, Shiratori Y, Kawase T, Nomura M, Omata M. Endoscopic variceal ligation is a sufficient procedure for the treatment of oesophageal varices in patients with hepatitis C liver cirrhosis: Comparison with injection sclerotherapy. J Gastroenterol Hepatol 1999; 14: 236-240
33. Gotoh Y, Iwakiri R, Sakata Y, Koyama T, Noda T, Matsunaga C, Ogata SI, Ishibashi S, Sakata H, Tsunada S, Fugimoto K. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: A prospective, controlled trial compared with endoscopic injection sclerotherapy. J Gastroenterol Hepatol 1999; 14: 241-244
34. Avgerinos A, Armonis A, Manolakopoulos S, Rekounis G, Argirakis G, Viazis N, Vlachogiannakos J, Adampoulos A, Kanaghinis T, Raptis SA. Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: A prospective multicenter randomized trial. Gastrointest Endosc 2000; 51: 652-658